Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses

Qi, Furong, Qian, Shen, Zhang, Shuye, Zhang, Zheng·2020·Biochemical and Biophysical Research Communications
DOI 10.1016/j.bbrc.2020.03.044

Cited by (912)

Items 301–400 of 912

  1. A Randomized Trial of Sitagliptin and Spironolactone With Combination Therapy in Hospitalized Adults With COVID-19
    Farhad Abbasi, Reuben Adatorwovor, Mohammad Ali Davarpanah, Yasaman Mansoori, Mehdi Hajiani, Farzan Azodi, Sepideh Sefidbakht, Shayesteh Davoudi, Farzana Rezaei, Shayan Mohammadmoradi et al. · 2022 · Journal of the Endocrine Society
  2. Viruses and amyloids - a vicious liaison
    Per Hammarström, Sofie Nyström · 2023 · Prion
  3. MAFLD in COVID-19 patients: an insidious enemy
    P. Dongiovanni, M. Meroni, M. Longo, A. Fracanzani · 2020 · Expert Review of Gastroenterology & Hepatology
  4. A modular framework for the development of targeted Covid-19 blood transcript profiling panels
    Darawan Rinchai, Basirudeen Syed Ahamed Kabeer, Mohammed Toufiq, Zohreh Tatari-Calderone, Sara Deola, Tobias Brummaier, Mathieu Garand, Ricardo Garcia Branco, Nicole E. Baldwin, Mohamed Alfaki et al. · 2020 · Journal of Translational Medicine
  5. Is Sex a Determinant of COVID-19 Infection? Truth or Myth?
    Leanne Groban, Hao Wang, Xuming Sun, Sarfaraz Ahmad, Carlos Maria Ferrario · 2020 · Current Hypertension Reports
  6. Single‐cell RNA sequencing analysis of SARS‐CoV‐2 entry receptors in human organoids
    Rajasekaran Mahalingam, Prakash Dharmalingam, Abirami Santhanam, Sivareddy Kotla, Gangarao Davuluri, Harry Karmouty‐Quintana, Ashrith Guha, Rajarajan A. Thandavarayan · 2020 · Journal of Cellular Physiology
  7. Angiotensin-converting enzyme 2, coronavirus disease 2019, and abdominal aortic aneurysms
    Baohui Xu, Gang Li, Jia Guo, Toru Ikezoe, Karthikeshwar Kasirajan, Sihai Zhao, Ronald L. Dalman · 2021 · Journal of Vascular Surgery
  8. One Health: EAACI Position Paper on coronaviruses at the human‐animal interface, with a specific focus on comparative and zoonotic aspects of SARS‐CoV‐2
    Anna D. J. Korath, Jozef Janda, Eva Untersmayr, Milena Sokołowska, Wojciech Feleszko, Ioana Octavia Agache, Ahmed Adel Seida, Katrin Hartmann, Erika Jensen‐Jarolim, Isabella Pali‐Schöll · 2021 · Allergy
  9. Evaluation of SARS-CoV-2 entry, inflammation and new therapeutics in human lung tissue cells
    Judith Grau-Expósito, David Perea, Marina Suppi, Núria Massana, Ander Vergara, María José Soler, Benjamin Trinité, Julià Blanco, Javier García‐Pérez, José Alcamı́ et al. · 2022 · PLoS Pathogens
  10. Influenza viruses and coronaviruses: Knowns, unknowns, and common research challenges
    Olivier Terrier, Mustapha Si‐Tahar, Mariette Ducatez, Christophe Chevalier, Andrés Pizzorno, Ronan Le Goffic, Thibaut Crépin, Gaëlle Simon, Nadia Naffakh · 2021 · PLoS Pathogens
  11. InterCellar enables interactive analysis and exploration of cell−cell communication in single-cell transcriptomic data
    Marta Interlandi, Kornelius Kerl, Martin Dugas · 2022 · Communications Biology
  12. Clinical status of patients 1 year after hospital discharge following recovery from COVID-19: a prospective cohort study
    Dapeng Li, Xuejiao Liao, Zhenghua Ma, Lina Zhang, Jingke Dong, Guoqin Zheng, Mei Zi, Wujian Peng, Lanlan Wei, Zhiyan Li et al. · 2022 · Annals of Intensive Care
  13. Analysis of SARS-CoV-2 viral loads in stool samples and nasopharyngeal swabs from COVID-19 patients in the United Arab Emirates
    Mariane Daou, Hussein Kannout, Mariam Khalili, Mohamed Almarei, Mohamed Alhashami, Zainab Alhalwachi, Fatima Yousif Alshamsi, Mohammad Tahseen Al Bataineh, Mohd Azzam Kayasseh, Abdulmajeed S. AlKhajeh et al. · 2022 · PLoS ONE
  14. Long COVID Definition, Symptoms, Risk Factors, Epidemiology and Autoimmunity: A Narrative Review
    Paweł Kozłowski, A. Leszczyńska, O. Ciepiela · 2024 · American Journal of Medicine Open
  15. SARS-CoV-2 Spike Protein Accumulation in the Skull-Meninges-Brain Axis: Potential Implications for Long-Term Neurological Complications in post-COVID-19
    Zhouyi Rong, Hongcheng Mai, Saketh Kapoor, Victor G. Puelles, Jan Czogalla, Julia Schädler, Jessica Vering, Claire Delbridge, Hanno Steinke, Hannah Frenzel et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  16. Attenuation of SARS-CoV-2 infection by losartan in human kidney organoids
    Rahmani, Waleed, Chung, Hyunjae, Sinha, Sarthak, Bui-Marinos, Maxwell P., Arora, Rohit, Jaffer, Arzina, Corcoran, Jennifer A., Biernaskie, Jeff, Chun, Justin · 2022 · iScience
  17. Emerging Therapeutic Modalities against COVID-19
    Shipra Malik, Anisha Gupta, Xiao‐bo Zhong, Theodore P. Rasmussen, José Enrique Manautou, Raman Bahal · 2020 · Pharmaceuticals
  18. Vascular underpinning of COVID-19
    Vanessa Kristina Wazny, Anthony Siau, Kan Xing Wu, Christine Cheung · 2020 · Open Biology
  19. How Do Inflammatory Mediators, Immune Response and Air Pollution Contribute to COVID-19 Disease Severity? A Lesson to Learn
    Cinzia Signorini, Patrizia Pignatti, Teresa Coccini · 2021 · Life
  20. COVID-19 and liver dysfunction: Epidemiology, association and potential mechanisms
    Min Du, Yang Song, Min Liu, Jue Liu · 2021 · Clinics and Research in Hepatology and Gastroenterology
  21. miRNAs: The Key Regulator of COVID-19 Disease
    Leyla Tahrani Hardin, Nan Xiao · 2022 · International Journal of Cell Biology
  22. Liver alterations and detection of SARS-CoV-2 RNA and proteins in COVID-19 autopsies
    Adrián Pesti, Krisztina Danics, Tibor Glasz, Tibor Várkonyi, Tamás Barbai, Andrea Reszegi, Ilona Kovalszky, Istvan T. Valyi-Nagy, Deján Dobi, Gábor Lotz et al. · 2022 · GeroScience
  23. Heterogeneity of hepatocyte dynamics restores liver architecture after chemical, physical or viral damage
    Inmaculada Ruz‐Maldonado, John T. González, Hanming Zhang, Jonathan Sun, Alicia Bort, Inamul Kabir, Richard Glenn Kibbey, Yajaira Suárez, Daniel M. Greif, Carlos F Fernandez-Hernando · 2024 · Nature Communications
  24. Clinical Features and Pathogenic Mechanisms of Gastrointestinal Injury in COVID-19
    Keiichi Mitsuyama, Kozo Tsuruta, Hidetoshi Takedatsu, Shinichiro Yoshioka, Masaru Morita, Mikio Niwa, Satoshi Matsumoto · 2020 · Journal of Clinical Medicine
  25. Can the Nasal Cavity Help Tackle COVID-19?
    Bissera Pilicheva, Radka Boyuklieva · 2021 · Pharmaceutics
  26. The Infectious Bronchitis Coronavirus Pneumonia Model Presenting a Novel Insight for the SARS-CoV-2 Dissemination Route
    Ekaterina V. Nefedova, Vyacheslav Yu. Koptev, Anna S. Bobikova, Viktoria Cherepushkina, Tatyana E. Mironova, V. N. Afonyushkin, Шкиль Николай Николаевич, Н. А. Донченко, Yulia N. Kozlova, N. A. Sigareva et al. · 2021 · Veterinary Sciences
  27. Traditional Chinese Medicine, Qingfei Paidu Decoction and Xuanfei Baidu Decoction, Inhibited Cytokine Production via NF-κB Signaling Pathway in Macrophages: Implications for Coronavirus Disease 2019 (COVID-19) Therapy
    Yujia Li, Bin Li, Pan Wang, Qinghua Wang · 2021 · Frontiers in Pharmacology
  28. Candidate genes of SARS-CoV-2 gender susceptibility
    Cristina Russo, Giovanna Morello, Roberta Malaguarnera, Salvatore Piro, Debora Lo Furno, Lucia Malaguarnera · 2021 · Scientific Reports
  29. SARS-CoV-2 Infection and Pancreatic β Cell Failure
    Keiichiro Mine, Seiho Nagafuchi, Hitoe Mori, Hirokazu Takahashi, Keizo Anzai · 2021 · Biology
  30. Discrimination and surveillance of infectious severe acute respiratory syndrome Coronavirus 2 in wastewater using cell culture and RT-qPCR
    Sílvia Monteiro, Daniela Rente, Mónica V. Cunha, Tiago André Marques, Eugénia Cardoso, João Vilaça, Norberta Coelho, Nuno Brôco, Marta Martins Carvalho, Ricardo Santos · 2022 · The Science of The Total Environment
  31. Liver Injury in Patients Hospitalized for COVID-19: Possible Role of Therapy
    Maurizio Gabrielli, Laura Franza, Alessandra Esperide, Gasparrini Irene, Antonio Gasbarrini, Francesco Franceschi, on behalf of GEMELLI AGAINST COVID 2019 · 2022 · Vaccines
  32. Dysregulation of endocytic machinery and ACE2 in small airways of smokers and COPD patients can augment their susceptibility to SARS-CoV-2 (COVID-19) infections
    Mathew Suji Eapen, Wenying Lu, Tillie‐Louise Hackett, Gurpreet Kaur Singhera, Isobel E. Thompson, Kielan Darcy McAlinden, Ashutosh Hardikar, Heinrich Christoph Weber, Greg Haug, Peter A. B. Wark et al. · 2020 · American Journal of Physiology-Lung Cellular and Molecular Physiology
  33. Coronavirus Receptors as Immune Modulators
    Charan Kumar V. Devarakonda, Emily K. Meredith, Mallika Ghosh, Linda H. Shapiro · 2020 · The Journal of Immunology
  34. Are asymptomatic gastrointestinal findings on imaging more common in COVID-19 infection? Study to determine frequency of abdominal findings of COVID-19 infection in patients with and without abdominal symptoms and in patients with chest-only CT scans
    Sree Harsha Tirumani, Ata A. Rahnemai‐Azar, Jonathan D. Pierce, Keval D. Parikh, Sooyoung Martin, Robert Gilkeson, Nikhil H. Ramaiya · 2021 · Abdominal Radiology
  35. Hypophosphatemia is an independent risk factor for AKI among hospitalized patients with COVID-19 infection
    Zijin Chen, Chenni Gao, Haijin Yu, Lin Lu, Jialin Liu, Wei Chen, Xiaogang Xiang, Hafiz Muhammad Jafar Hussain, Benjamin J. Lee, Chuanlei Li et al. · 2021 · Renal Failure
  36. Potential COVID‐19 therapeutic approaches targeting angiotensin‐converting enzyme 2; An updated review
    Saba Zanganeh, Nima Goodarzi, Mohammad Doroudian, Elaheh Movahed · 2021 · Reviews in Medical Virology
  37. Liver Injury in Patients with COVID-19 without Underlying Liver Disease
    Monika Pazgan−Simon, Syłwia Serafińska, Michał Kukla, Marta Kucharska, Jolanta Zuwała−Jagiełło, Iwona Buczyńska, Kamila Zielińska, Krzysztof Adam Simon · 2022 · Journal of Clinical Medicine
  38. COVID-19: gastrointestinal and hepatobiliary manifestations
    Angela R. Shih, Joseph Misdraji · 2022 · Human Pathology
  39. Safety perspectives on presently considered drugs for the treatment of COVID‐19
    Sophie L. Penman, Robyn T. Kiy, Rebecca L. Jensen, Christopher Beoku Betts, Ana Alfirevic, David J. Back, Saye Khoo, Andrew Owen, Munir Pirmohamed, B. Kevin Park et al. · 2020 · British Journal of Pharmacology
  40. The effect of Chinese herbal medicine on digestive system and liver functions should not be neglected in COVID‐19: An updated systematic review and meta‐analysis
    Shihua Shi, Fei Wang, Li Jiang, Yulong Li, Weihao Li, Xiaoping Wu, Shuo Kou, Yongcan Wu, Xiaomin Wang, Caixia Pei et al. · 2021 · IUBMB Life
  41. COVID‐19 in gastroenterology: Where are we now? Current evidence on the impact of COVID‐19 in gastroenterology
    Fernando Magro, Alexandre Nuzzo, Cândida Abreu, Diogo Libânio, Iago Rodríguez–Lago, Katarzyna Monika Pawlak, Marcus Hollenbach, Willem Pieter Brouwer, Keith Siau · 2021 · United European Gastroenterology Journal
  42. Heterocellular N-cadherin junctions enable nontransformed cells to inhibit the growth of adjacent transformed cells
    Stephanie A. Sheehan, Kelly L. Hamilton, Edward P. Retzbach, Premalatha Balachandran, Harini Krishnan, Paola Leone, Gary S. Goldberg · 2022 · Cell Communication and Signaling
  43. Comprehensive Oncogenic Features of Coronavirus Receptors in Glioblastoma Multiforme
    Anjing Chen, Wenguo Zhao, Xiaolong Li, Guangyu Sun, Zhaoyin Ma, Lingyu Peng, Zhongyang Shi, Xingang Li, Jie Yan · 2022 · Frontiers in Immunology
  44. SARS-CoV-2 mechanisms of cell tropism in various organs considering host factors
    Emad Behboudi, Seyed Nooreddin Faraji, Gholamreza Daryabor, Seyed Mohammad Ali Hashemi, Maryam Asadi, Fahime Edalat, Mohammad Javad Raee, Gholamreza Hatam · 2024 · Heliyon
  45. Molecular cross-talk between long COVID-19 and Alzheimer’s disease
    Magdalena Pszczołowska, Kamil Walczak, Weronika Miśków, Katarzyna Antosz, Joanna Batko, Julia Karska, Jerzy Leszek · 2024 · GeroScience
  46. Pharmacological basis for the potential role of Azithromycin and Doxycycline in management of COVID-19
    Ahmed S. Ali, Mai A. ASattar, Shahid Karim, Dina Kutbi, Hanin Aljohani, Duaa Bakhshwin, Mohammed Alsieni, Huda Mohammed Alkreathy · 2021 · Arabian Journal of Chemistry
  47. COVID-19 and the liver: What do we know so far?
    Prashant Nasa, George Alexander · 2021 · World Journal of Hepatology
  48. Zinc supplementation augments the suppressive effects of repurposed NF-κB inhibitors on ACE2 expression in human lung cell lines
    Ming‐Cheng Lee, Yin‐Kai Chen, Jyy-Jih Tsai-Wu, Yih‐Jen Hsu, Bor‐Ru Lin · 2021 · Life Sciences
  49. RETRACTED: Analysis of 329,942 SARS-CoV-2 records retrieved from GISAID database
    Maria A. Zelenova, Anna Ivanova, Semyon Semyonov, Yuriy V. Gankin · 2021 · Computers in Biology and Medicine · Retracted
  50. Before the “cytokine storm”: Boosting efferocytosis as an effective strategy against SARS-CoV-2 infection and associated complications
    Somit Dutta, Amartya Mukherjee, Upendra Nongthomba · 2022 · Cytokine & Growth Factor Reviews
  51. Organoid Models of SARS-CoV-2 Infection: What Have We Learned about COVID-19?
    Bang M. Tran, Georgia Deliyannis, Abderrahman Hachani, Linda Earnest, Joseph Torresi, Elizabeth Vincan · 2022 · Organoids
  52. Acute angle-closure glaucoma concurrent with COVID 19 infection; case report
    Sedat Özmen, Nilgün Özkan Aksoy, Burçin Köklü Çakır, Gürsoy Alagöz · 2022 · European Journal of Ophthalmology
  53. SARS-CoV-2 and the central nervous system: Emerging insights into hemorrhage-associated neurological consequences and therapeutic considerations
    Joy Mitra, Manohar M. Kodavati, Vincent E. Provasek, K. S. Jagannatha Rao, SANKAR P. MITRA, Dale J. Hamilton, Philip J. Horner, Farhaan Vahidy, Gavin Wayne Britz, Thomas A. Kent et al. · 2022 · Ageing Research Reviews
  54. Plasma metabolome and cytokine profile reveal glycylproline modulating antibody fading in convalescent COVID-19 patients
    Zhu Yang, Di Wu, Shanxin Lu, Yang Qiu, Zhengyi Hua, Fancheng Tan, Cixiong Zhang, Lei Zhang, Dingyu Zhang, Xi Zhou et al. · 2022 · Proceedings of the National Academy of Sciences
  55. Alterations of the gut microbiota in coronavirus disease 2019 and its therapeutic potential
    Hui Xiang, Qiping Liu · 2022 · World Journal of Gastroenterology
  56. Molecular and immune signatures, and pathological trajectories of fatal COVID‐19 lungs defined by in situ spatial single‐cell transcriptome analysis
    Arun Das, Wen Meng, Zhentao Liu, Md Musaddaqul Hasib, Hugh Galloway, Suzane Ramos da Silva, Luping Chen, Gabriel Sica, Alberto Paniz‐Mondolfi, Clare Bryce et al. · 2023 · Journal of Medical Virology
  57. Cell atlas of the Atlantic salmon spleen reveals immune cell heterogeneity and cell-specific responses to bacterial infection
    Jianxuan Sun, Rose Ruiz Daniels, Adam Balic, Adriana Magalhães Santos Andresen, Håvard Bjørgen, Ross Dobie, Neil Cowan Henderson, Erling Olaf Koppang, Samuel Martín, Johanna Hol Fosse et al. · 2024 · Fish & Shellfish Immunology
  58. Genetic and epigenetic control of ACE2 expression and its possible role in COVID ‐19
    Rafael Silva Lima, Luiz Paulo Carvalho Rocha, Paula Rocha Moreira · 2021 · Cell Biochemistry and Function
  59. Immunomodulation: Immunoglobulin Preparations Suppress Hyperinflammation in a COVID-19 Model via FcγRIIA and FcαRI
    Fabian Bohländer, Dennis Riehl, Sabrina Weißmüller, Marcus Gutscher, Jörg Schüttrumpf, Stefanie Faust · 2021 · Frontiers in Immunology
  60. Single Nucleus Multiomic Profiling Reveals Age-Dynamic Regulation of Host Genes Associated with SARS-CoV-2 Infection
    Allen Wang, Joshua Chiou, Olivier Poirion, Justin Buchanan, Michael J. Valdez, Jamie M. Verheyden, Xiaomeng Hou, Minzhe Guo, Jacklyn M. Newsome, Parul Kudtarkar et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  61. 3D Bioprinting for fabrication of tissue models of COVID-19 infection
    Anisha Kabir, Pallab Datta, Julia Oh, Adam Williams, Veli Özbolat, Derya Unutmaz, Ibrahim Tarik Ozbolat · 2021 · Essays in Biochemistry
  62. HCV Infection Increases the Expression of ACE2 Receptor, Leading to Enhanced Entry of Both HCV and SARS-CoV-2 into Hepatocytes and a Coinfection State
    Tom Domovitz, Samer Ayoub, Michal Werbner, Joel Alter, Lee S. Izhaki-Tavor, Yfat Yahalom-Ronen, Evgeny Tikhonov, Tomer Meirson, Yaakov Maman, Nir Paran et al. · 2022 · Microbiology Spectrum
  63. SARS-CoV-2—Morphology, Transmission and Diagnosis during Pandemic, Review with Element of Meta-Analysis
    Katarzyna Grudlewska‐Buda, Natalia Wiktorczyk-Kapischke, Ewa Wałecka-Zacharska, Joanna Kwiecińska-Piróg, Katarzyna Buszko, Kamil Leis, Klaudia Juszczuk, Eugenia Gospodarek-Komkowska, Krzysztof Skowron · 2021 · Journal of Clinical Medicine
  64. Neuropsychiatric Disorders and COVID-19: What We Know So Far
    Fernanda Majolo, Guilherme Liberato da Silva, Lucas Vieira, Cetin Anli, Luís Fernando Saraiva Macedo Timmers, Stefan Laufer, Márcia Inês Goettert · 2021 · Pharmaceuticals
  65. Is the epithelial barrier hypothesis the key to understanding the higher incidence and excess mortality during COVID‐19 pandemic? The case of Northern Italy
    Silvana Fiorito, Marzia Soligo, Yadong Gao, İsmail Öğülür, Cezmi A. Akdiş, Sergio Bonini · 2022 · Allergy
  66. Goblet Cell Hyperplasia Increases SARS-CoV-2 Infection in COPD
    Jaspreet Kaur Osan, Sattya Narayan Talukdar, Friederike Feldmann, Beth Ann DeMontigny, Kailey Jerome, Kristina L. Bailey, Heinz Feldmann, Masfique Mehedi · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  67. Ulcerative Colitis in a COVID-19 Patient: A Case Report
    Muhammet Fatih Aydın, Hamit Taşdemir · 2021 · The Turkish Journal of Gastroenterology
  68. The use of single-cell RNA-seq to study heterogeneity at varying levels of virus–host interactions
    Sharmada Swaminath, Alistair B. Russell · 2024 · PLoS Pathogens
  69. Can SARS-CoV-2 be transmitted via faeces?
    Ines B. Moura, Anthony M. Buckley, Mark H. Wilcox · 2021 · Current Opinion in Gastroenterology
  70. SARS-CoV-2 Infection and Liver Disease: A Review of Pathogenesis and Outcomes
    Luke Baldelli, Thomas Marjot, Eleanor J. Barnes, Alfred Sidney Barritt, Gwilym James Webb, Andrew M. Moon · 2022 · Gut and Liver
  71. COVID-19 associated liver injury: An updated review on the mechanisms and management of risk groups
    Yue Shi, Mina Wang, Liqun Wu, Xuexin Li, Zehuan Liao · 2023 · Liver Research
  72. COVID-19-induced gastrointestinal autonomic dysfunction: A systematic review
    Reem M Elbeltagi, Mohammed Al‐Beltagi, Nermin Kamal Saeed, Adel Salah Bediwy · 2023 · World Journal of Clinical Cases
  73. High-altitude populations need special considerations for COVID-19
    Arnar Breevoort, Giovanni A. Carosso, Mohammed A. Mostajo-Radji · 2020 · Nature Communications
  74. Inflammatory Bowel Disease and COVID-19: How Microbiomics and Metabolomics Depict Two Sides of the Same Coin
    Gian Mario Cortes, Maria Antonietta Marcialis, Flaminia Bardanzellu, Angelica Corrias, Vassilios Fanos, Michele Mussap · 2022 · Frontiers in Microbiology
  75. Evidence that Maackia amurensis seed lectin (MASL) exerts pleiotropic actions on oral squamous cells with potential to inhibit SARS-CoV-2 infection and COVID-19 disease progression
    Stephanie A. Sheehan, Kelly L. Hamilton, Edward P. Retzbach, Premalatha Balachandran, Harini Krishnan, Paola Leone, Moisés López-González, Shraddha Suryavanshi, Pradeep Kumar, Riccardo Russo et al. · 2021 · Experimental Cell Research
  76. ACE2, the Counter-Regulatory Renin–Angiotensin System Axis and COVID-19 Severity
    Filippos K. Triposkiadis, Andrew V. Xanthopoulos, Grigorios Giamouzis, Konstantinos Dean Boudoulas, Randall C. Starling, John S. Skoularigis, Harisios K Boudoulas, Efstathios K. Iliodromitis · 2021 · Journal of Clinical Medicine
  77. The Impact of COVID-19 Pandemic on Dermatological Conditions: A Novel, Comprehensive Review
    Gehan A. Pendlebury, Peter Oro, William Haynes, Drew Merideth, Samantha J Bartling, Michelle A. Bongiorno · 2022 · Dermatopathology
  78. AI-CoV Study: Autoimmune Encephalitis Associated With COVID-19 and Its Vaccines—A Systematic Review
    M. M. Samim, Debjyoti Dhar, Sheetal Goyal, Treshita Dey, Naznin Parvin, Rutul Shah, Vikram Singh, Sampurna Chowdhury, Bhavesh Mohan Lal, Nibu Varghese et al. · 2022 · Journal of Clinical Neurology
  79. Comparison of Vitamin D and Resveratrol Performances in COVID-19
    Cristina Russo, Maria Stella Valle, Luisa Malaguarnera, Ivana Roberta Romano, Lucia Malaguarnera · 2023 · Nutrients
  80. Histopathological impact of SARS-CoV-2 on the liver: Cellular damage and long-term complications
    Alfonso Rodriguez-Espada, Moisés Salgado-de la Mora, Briana Rodriguez-Paniagua, Nathaly Limon‐de la Rosa, Mónica Itzel Martínez-Gutiérrez, Santiago Pastrana-Brandes, Nalu Navarro–Álvarez · 2024 · World Journal of Gastroenterology
  81. Redox Homeostasis and Immune Alterations in Coronavirus Disease-19
    Francesco Bellanti, Aurelio Lo Buglio, Gianluigi Vendemiale · 2022 · Biology
  82. Zebrafish models of COVID-19
    Sylwia D. Tyrkalska, Sergio Candel, Annamaria Pedoto, Diana García‐Moreno, Francisca Alcaraz‐Pérez, Álvaro Sánchez‐Ferrer, María Luisa Cayuela, Víctoriano Mulero · 2022 · FEMS Microbiology Reviews
  83. Therapeutic Effects of Cannabinoids and Their Applications in COVID-19 Treatment
    Rebeca Pérez, Talita Glaser, Cecilia Villegas, Viviana Burgos, Henning Ulrich, Cristian Paz · 2022 · Life
  84. COVID-19 and diabetes: Is this association driven by the DPP4 receptor? Potential clinical and therapeutic implications
    Ilaria Barchetta, Maria Gisella Cavallo, Marco Giorgio Baroni · 2020 · Diabetes Research and Clinical Practice
  85. Ivermectin for COVID-19 Treatment: Clinical Response at Quasi-Threshold Doses Via Hypothesized Alleviation of CD147-Mediated Vascular Occlusion
    David E. Scheim · 2020 · SSRN Electronic Journal
  86. Hypotheses and facts for genetic factors related to severe COVID-19
    Stanislav Vasilev Kotsev, Dimitrina Miteva, Stanislava Krayselska, Martina Shopova, Maria Pishmisheva, Spaska Angelova Stanilova, Tsvetelina Veselinova Velikova · 2021 · World Journal of Virology
  87. Shedding light on toxicity of SARS-CoV-2 peptides in aquatic biota: A study involving neotropical mosquito larvae (Diptera: Culicidae)
    Juliana Moreira Mendonça-Gomes, Ives Charlie‐Silva, Abraão Tiago Batista Guimarães, Fernanda Neves Estrela, Marilia Freitas Calmon, Rafael Nava Miceli, Paulo Ricardo da Silva Sanches, Cíntia Bittar, Paula Rahal, Eduardo Maffud Cilli et al. · 2021 · Environmental Pollution
  88. Duodenal tropism of SARS-CoV-2 and clinical findings in critically ill COVID-19 patients
    Michael Neuberger, Achim A. Jungbluth, Michael Irlbeck, Florian Streitparth, Maria Burian, Thomas Kirchner, Jens Werner, Martina Rudelius, Thomas Knösel · 2022 · Infection
  89. Potential interactions of SARS‐CoV‐2 with human cell receptors in the skin: Understanding the enigma for a lower frequency of skin lesions compared to other tissues
    Paulo Ricardo Criado, Thaís Pincelli, Roberta Fachini Jardim Criado, Beatrice Martinez Zugaib Abdalla, Walter Belda · 2020 · Experimental Dermatology
  90. SARS-CoV-2 Host Receptor ACE2 Protein Expression Atlas in Human Gastrointestinal Tract
    Xiang An, Wenlong Lin, Huan Liu, Weixiang Zhong, Xiuming Zhang, Yimin Zhu, Xiaojian Wang, Jun Li, Qinsong Sheng · 2021 · Frontiers in Cell and Developmental Biology
  91. Adipose tissue dysfunction and MAFLD in obesity on the scene of COVID-19
    Adryana Cordeiro, Amanda Ribamar, Andréa Ramalho · 2021 · Clinics and Research in Hepatology and Gastroenterology
  92. D-dimer and CoV-2 spike-immune complexes contribute to the production of PGE2 and proinflammatory cytokines in monocytes
    Yun-Jong Park, David I. Acosta, Russell A. Vassell, Juanjie Tang, Surender Khurana, Carol D. Weiss, Hana Golding, Marina B. Zaitseva · 2022 · PLoS Pathogens
  93. SARS-CoV-2: An Overview of the Genetic Profile and Vaccine Effectiveness of the Five Variants of Concern
    Raluca Dumache, Alexandra Enache, Ioana Gabriela Macasoi, Cristina Adriana Dehelean, Victor Cristian Dumitrascu, Alexandra Mihailescu, Roxana Popescu, Mihaela Vlad, Cristian Sebastian Vlad, Camelia Oana Mureşan · 2022 · Pathogens
  94. The Associations between Cytokine Levels, Kidney and Heart Function Biomarkers, and Expression Levels of Angiotensin-Converting Enzyme-2 and Neuropilin-1 in COVID-19 Patients
    Rabab Hussain Sultan, Maged Abdallah, Tarek Mohamed Ali, Amr E. Ahmed, Hebatallah Hany Assal, Basem Hassan Elesawy, Osama M. Ahmed · 2022 · Vaccines
  95. Incidence and predisposing factors for de novo post-COVID-19 irritable bowel syndrome
    Mehreen Siyal, Zaigham Abbas, Javeria Ashraf, Muhammad Ali Qadeer, Abeer Altaf · 2022 · European Journal of Gastroenterology & Hepatology
  96. COVID-19 and Coronaviral Hepatitis: Evidence of Collateral Damage
    Mohammad Khalid Parvez · 2020 · Future Virology
  97. Landscape of SARS-CoV-2 spike protein-interacting cells in human tissues
    Bingfeng Zheng, Manman Yuan, Qinhai Ma, Shenglan Wang, Yang Tan, Yizhu Xu, Jing Ye, Yanjie Gao, Xueqing Sun, Zifeng Yang et al. · 2021 · International Immunopharmacology
  98. COVID-19 and liver diseases, what we know so far
    Mohamed Elnaggar, Ahmed Abomhya, Ismail Elkhattib, Nabila Dawoud, Rajkumar Prakashbhai Doshi · 2022 · World Journal of Clinical Cases
  99. An improved Fuzzy based GWO algorithm for predicting the potential host receptor of COVID-19 infection
    Amika Achom, Ranjita Das, Partha Pakray · 2022 · Computers in Biology and Medicine
  100. The controversial effect of smoking and nicotine in SARS-CoV-2 infection
    Zahra Salehi, B. Fatemeh Nobakht M. Gh, Yazdan Hasani Nourian, Sadegh Azimzadeh Jamalkandi, Mostafa Ghanei · 2023 · Allergy Asthma and Clinical Immunology